Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209–249

PubMed  Google Scholar 

Racial Disparities in Cancer Survival Among Randomized Clinical Trials Patients of the Southwest Oncology Group | JNCI Journal of the National Cancer Institute | Oxford Academic [Internet]. [cited 2024 Jan 2]. Available from: https://academic.oup.com/jnci/article/101/14/984/2515685

Coleman MP, Forman D, Bryant H, Butler J, Rachet B, Maringe C et al (2011) Cancer survival in Australia, Canada, Denmark, Norway, Sweden, and the UK, 1995–2007 (the International Cancer Benchmarking Partnership): an analysis of population-based cancer registry data. Lancet 377(9760):127–138

Article  PubMed  CAS  Google Scholar 

Amin MB, Greene FL, Edge SB, Compton CC, Gershenwald JE, Brookland RK et al (2017) The Eighth Edition AJCC Cancer Staging Manual: Continuing to build a bridge from a population-based to a more personalized approach to cancer staging. CA Cancer J Clin 67(2):93–99

PubMed  Google Scholar 

Eisenhauer EA, Therasse P, Bogaerts J, Schwartz LH, Sargent D, Ford R et al (2009) New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247

Article  PubMed  CAS  Google Scholar 

Green MC, Buzdar AU, Smith T, Ibrahim NK, Valero V, Rosales MF et al (2005) Weekly paclitaxel improves pathologic complete remission in operable breast cancer when compared with paclitaxel once every 3 weeks. J Clin Oncol 23(25):5983–5992

Article  PubMed  CAS  Google Scholar 

Nair N, Shet T, Parmar V, Havaldar R, Gupta S, Budrukkar A et al (2018) Breast cancer in a tertiary cancer center in India-An audit, with outcome analysis. Indian J Cancer 55(1):16–22

Article  PubMed  Google Scholar 

Gogia A, Deo SVS, Shukla NK, Mathur S, Sharma DN, Tiwari A (2018) Clinicopathological profile of breast cancer: An institutional experience. Indian J Cancer 55(3):210–213

Article  PubMed  Google Scholar 

Upadhyay AK, Prakash A, Upadhyay A Clinicopathological Profile of Breast Cancer at a Tertiary Cancer Center in Jharkhand, India: A Descriptive Cohort Study. Cureus [Internet]. 2023 [cited 2024 Jan 3];15(6). Available from: https://www.cureus.com/articles/154826-clinicopathological-profile-of-breast-cancer-at-a-tertiary-cancer-center-in-jharkhand-india-a-descriptive-cohort-study.pdf

Ghosh J, Gupta S, Desai S, Shet T, Radhakrishnan S, Suryavanshi P et al (2011) Estrogen, progesterone and HER2 receptor expression in breast tumors of patients, and their usage of HER2-targeted therapy, in a tertiary care centre in India. Indian J Cancer 48(4):391–396

Article  PubMed  CAS  Google Scholar 

Doval DC, Sharma A, Sinha R, Kumar K, Dewan AK, Chaturvedi H et al (2015) Immunohistochemical profile of breast cancer patients at a tertiary care hospital in New Delhi, India. Asian Pac J Cancer Prev 16(12):4959–4964

Article  PubMed  Google Scholar 

Kumar RV, Panwar D, Amirtham U, Premalata CS, Gopal C, Narayana SM et al (2018) Estrogen receptor, Progesterone receptor, and human epidermal growth factor receptor-2 status in breast cancer: A retrospective study of 5436 women from a regional cancer center in South India. South Asian J Cancer 07(1):7–10

Article  Google Scholar 

Datkhile KD, Gudur AK, Gudur RA, Bhosale SJ (2022) A hospital-based cross-sectional study on assessment of ER, PR, and Her2 status in breast cancer patients from tertiary-care hospital of rural Maharashtra. Indian J Cancer 59(1):144

Article  PubMed  Google Scholar 

Survival in breast cancer: A population-based study in Bangalore, India - Nandakumar – 1995 - International Journal of Cancer - Wiley Online Library [Internet]. [cited 2024 Jan 3]. Available from: https://onlinelibrary.wiley.com/doi/abs/https://doi.org/10.1002/ijc.2910600504

A population-based survival study on female breast cancer in Madras, India | British Journal of Cancer [Internet]. [cited 2024 Jan 3]. Available from: https://www.nature.com/articles/bjc1997137

Soerjomataram I, Louwman MWJ, Ribot JG, Roukema JA, Coebergh JWW (2008) An overview of prognostic factors for long-term survivors of breast cancer. Breast Cancer Res Treat 107(3):309–330

Article  PubMed  CAS  Google Scholar 

Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N et al (2014) Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis. Lancet 384(9938):164–172

Article  PubMed  Google Scholar